Academic Publication The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
VFDB 2025: an integrated resource for exploring anti-virulence compounds
Abstract With the escalating crisis of bacterial multidrug resistance, anti-virulence therapeutic strategies have emerged as a highly promising alternative to conventional antibiotic...
Immune Suppression and Antimicrobial Resistance in Hospitalised HIV Patients: Evidence from Free State and Northern Cape Hospitals.
Background: Globally, studies has shown that microorganism infections are responsible for high rate of morbidity and mortality among immune-compromised patients. Such an increase is being observed ...
Genomic convergence of multidrug resistance, virulence-associated loci, and phage defense systems in Klebsiella pneumoniae from pharmaceutical wastewater in Bangladesh
Scientific Reports - Genomic convergence of multidrug resistance, virulence-associated loci, and phage defense systems in Klebsiella pneumoniae from pharmaceutical wastewater in Bangladesh
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
No description provided.
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study
No description provided.
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance'?
This literature focuses on:
What other academic literature is closely related to 'The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance'?
Yes, highly correlated activity was mapped. An entry titled 'VFDB 2025: an integrated resource for exploring anti-virulence compounds' discusses this: Abstract With the escalating crisis of bacterial multidrug resistance, anti-virulence therapeutic strategies have emerged as a highl...
Are there commercial applications of 'The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance' in market news publications?
Yes, highly correlated activity was mapped. An entry titled 'Genomic convergence of multidrug resistance, virulence-associated loci, and phage defense systems in Klebsiella pneumoniae from pharmaceutical wastewater in Bangladesh' discusses this: Scientific Reports - Genomic convergence of multidrug resistance, virulence-associated loci, and phage defense systems in Klebsiella pneumoniae fro...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
SaaS Metrics